Rankings
▼
Calendar
RXST Q4 2024 Earnings — RxSight, Inc. Revenue & Financial Results | Market Cap Arena
RXST
RxSight, Inc.
$313M
Q4 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$40M
+40.7% YoY
Gross Profit
$29M
71.6% margin
Operating Income
-$9M
-21.5% margin
Net Income
-$6M
-14.8% margin
EPS (Diluted)
$-0.15
QoQ Revenue Growth
-11.4%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$5M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$319M
Total Liabilities
$37M
Stockholders' Equity
$281M
Cash & Equivalents
$17M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$40M
$29M
+40.7%
Gross Profit
$29M
$18M
+63.1%
Operating Income
-$9M
-$11M
+20.5%
Net Income
-$6M
-$9M
+35.3%
Revenue Segments
L D D
$11M
91%
Service Warranty Service Contracts And Accessories
$1M
9%
← FY 2024
All Quarters
Q1 2025 →